Abstract Number ‐ 213: Single Center Experience of Intrathecal Nicardipine Use in The Treatment of Vasospasm‐ Lessons Learned
Introduction Symptomatic cerebral vasospasm and delayed cerebral ischemia (DCI) following aneurysmal subarachnoid hemorrhage leads to significant morbidity and mortality. Intrathecal (IT) nicardipine has been shown to improve outcome and reduce DCIin retrospective cohort studies1. Ecological validit...
Main Authors: | Aaisha Siddiqua Mozumder, Anqi Luo, Davana Ramaswamy, Shadman Sakib Mozumder, Firas Kaddouh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-03-01
|
Series: | Stroke: Vascular and Interventional Neurology |
Online Access: | https://www.ahajournals.org/doi/10.1161/SVIN.03.suppl_1.213 |
Similar Items
-
Abstract Number ‐ 69: Intrathecal Nicardipine for Severe Intractable Reversible Cerebral Vasoconstriction Syndrome (RCVS): A Novel Case Report
by: Colin Wakefield, et al.
Published: (2023-03-01) -
Nicardipine Loaded Solid Phospholipid Extrudates for the Prevention of Cerebral Vasospasms: In Vitro Characterization
by: Christin Zlomke, et al.
Published: (2020-08-01) -
Safety and Tolerability of Concentrated Intraventricular Nicardipine for Poor-Grade Aneurysmal Subarachnoid Hemorrhage–Related Vasospasm
by: Kaneez Zahra, et al.
Published: (2023-02-01) -
Microvascular cerebral blood flow response to intrathecal nicardipine is associated with delayed cerebral ischemia
by: Eashani Sathialingam, et al.
Published: (2023-03-01) -
Abstract 092: Vasospasm as a Consequence of IVIg Usage for GBS.
by: Connor D Welsh
Published: (2023-11-01)